Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2014
08/27/2014EP2768454A1 Removable covering and interactive packaging
08/26/2014US8816066 Cellulose interpolymers and methods of oxidation
08/26/2014US8815959 Oil-in-water emulsion composition and method for producing same
08/26/2014US8815944 Pharmaceutical composition with gelling properties containing a tyrosine derivative
08/26/2014US8815938 Double compartment skincare products comprising avermectin/milbemycin compounds
08/26/2014US8815931 Oral formulations for tetrapyrrole derivatives
08/26/2014US8815916 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
08/26/2014US8815912 Wound and mucosa antiseptic based on bispyridiniumalkanes
08/26/2014US8815911 Alfentanil composition for the treatment of acute pain
08/26/2014US8815838 Aerosol fluoroquinolone formulations for improved pharmacokinetics
08/26/2014US8815816 Topical application of ivermectin for the treatment of dermatological conditions/afflictions
08/26/2014US8815801 Controlled release composition and method of producing the same
08/26/2014US8815795 Methods for preventing or treating eye diseases using adiponectin
08/26/2014US8815599 Methods and compositions for the inhibition of gene expression
08/26/2014US8815326 Temperature telemetry in processing of material
08/26/2014US8815311 Methods for improving thyroid function in a subject
08/26/2014US8815302 Calcium carbonate granulation
08/26/2014US8815295 Anti respiratory syncytial virus peptide functionalized gold nanoparticles
08/26/2014US8815294 Pharmaceutical compositions of dextran polymer derivatives and a carrier material
08/26/2014US8815293 Organic compounds
08/26/2014US8815292 Compositions and methods for treating insulin resistance and diabetes mellitus
08/26/2014US8815291 Particles comprising a releasable dopant therein
08/26/2014US8815290 Rapidly disintegrating gelatinous coated tablets
08/26/2014US8815289 Tamper resistant dosage forms
08/26/2014US8815288 Oral dosage formulation containing both immediate-release and sustained-release drugs for treating neurodegenerative disorders
08/26/2014US8815287 Opiod agonist formulations with releasable and sequestered antagonist
08/26/2014US8815286 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
08/26/2014US8815285 Extended release dosage forms of metoprolol
08/26/2014US8815284 Bioerodible sustained release drug delivery systems
08/26/2014US8815283 Immuno-compatible hydrogel system
08/26/2014US8815282 Commercial method for production of room temperature-liquid cetyl myristoleate
08/26/2014US8815277 In situ forming hydrogel and biomedical use thereof
08/26/2014US8815263 Tandem facial amphiphiles
08/26/2014US8815261 Composition for external application comprising aripiprazole and organic acid as active ingredients
08/26/2014US8815260 Treatment of restenosis and stenosis with dasatinib
08/26/2014US8815259 Drug eluting superhydrophobic coatings
08/26/2014US8815258 Compositions, methods and systems for respiratory delivery of two or more active agents
08/26/2014US8815257 Compositions comprising metathesized unsaturated polyol esters
08/26/2014US8815256 Induction of tumor immunity by variants of folate binding protein
08/26/2014US8815253 Compositions for inducing immune responses
08/26/2014US8815228 Alloplastic injectable dermal filler and methods of use thereof
08/26/2014US8815212 Nanocarriers for imaging and therapy applications
08/26/2014US8814837 Simple device for treating tinea unguium
08/26/2014US8814819 Glaucoma treatment device
08/26/2014CA2800428C Treatment of type 2 diabetes
08/26/2014CA2765852C Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
08/26/2014CA2729819C Unit dosage of apadenoson
08/26/2014CA2672284C Human growth hormone formulations
08/26/2014CA2646255C High delivery rates for lipid based drug formulations, and methods of treatment thereof
08/26/2014CA2643431C A method for industrial production of biocatalysts in the form of enzymes or microorganisms immobilized in polyvinyl alcohol gel, their use and devices for their production
08/26/2014CA2642414C Rapid release irbesartan-containing pharmaceutical composition
08/26/2014CA2634272C Adhesive patch and production method thereof
08/26/2014CA2589137C Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
08/26/2014CA2585363C Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
08/26/2014CA2523620C Drug releasing biodegradable fiber for delivery of therapeutics
08/21/2014WO2014127357A1 Supramolecular magnetic nanoparticles
08/21/2014WO2014127245A1 Treatment of klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014WO2014127243A1 Sustained drug delivery implant
08/21/2014WO2014127118A1 Anise flavored medication
08/21/2014WO2014127116A1 Topical ocular analgesic agents
08/21/2014WO2014126969A1 Solid dispersions of low-water solubility actives
08/21/2014WO2014126594A1 Treatment of evolving bacterial resistance diseases including klebsiella pneumoniae with liposomally formulated glutathione
08/21/2014WO2014126541A1 Pharmaceutical compositions used in treating bacterial infections
08/21/2014WO2014126536A1 Photo-responsive macro- and micro- liquid marbles
08/21/2014WO2014126370A1 Film-forming pharmaceutical composition for wound healing and method for preparing the same
08/21/2014WO2014126267A1 Difluprednate emulsion composition containing antimicrobial metal
08/21/2014WO2014126266A1 Difluprednate emulsion composition containing zinc
08/21/2014WO2014125352A1 Pharmaceutical compositions comprising tadalafil
08/21/2014WO2014125343A1 Tadalafil tablet composition with reduced dose strength
08/21/2014WO2014125340A1 Smoke liquid for atomizers and/or vaporizers
08/21/2014WO2014125256A1 Nanoparticle delivery compositions
08/21/2014WO2014125124A1 Solid pharmaceutical dosage form of dolutegravir
08/21/2014WO2014125085A1 Oral pharmaceutical formulations comprising nimesulide and thiocolchicoside
08/21/2014WO2014125052A1 Pharmaceutical composition for oral administration comprising fexofenadine and process for preparing thereof
08/21/2014WO2014124981A1 Chewable composition for oral administration and process for preparing thereof
08/21/2014WO2014124803A1 Plant extract of inula racemosa
08/21/2014WO2014124700A1 Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets
08/21/2014WO2014106048A3 Liquid topical pharmaceutical nano-emulsion formulations
08/21/2014WO2014078180A3 Coated devices for the administration of autologous biological molecules and for the isolation and elution of proteins from plasma
08/21/2014WO2014047496A3 Spray drying microcapsules
08/21/2014WO2013121452A8 Product comprising glucomannan and chitosan for the treatment of gastroesophageal reflux disease
08/21/2014US20140236080 Pary-xylene based microfilm elution devices
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140235730 Solid, edible, chewable laxative composition
08/21/2014US20140235729 Benzylamine containing compositions and methods for appetite suppression
08/21/2014US20140235725 Preconfigured gel with infused drug for ultrasound
08/21/2014US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/21/2014US20140235720 Treating patients with intravenous ibuprofen
08/21/2014US20140235712 Conformable coating and composition
08/21/2014US20140235710 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
08/21/2014US20140235709 Orally dispersible tablet
08/21/2014US20140235691 Stable Preservative-free Mydriatic and Anti-inflammatory Solutions for Injection
08/21/2014US20140235688 Treatment of external parasites by oral administration of parasiticidal agents
08/21/2014US20140235678 Topical Ophthalmological Pharmaceutical Composition containing Sorafenib
08/21/2014US20140235664 Stable pharmaceutical formulations of methylnaltrexone
08/21/2014US20140235662 Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
08/21/2014US20140235656 Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
08/21/2014US20140235618 Methods for treatment of atopic dermatitis and inflammatory skin disorders
08/21/2014US20140235598 Tablet containing dehydroepiandrosterone (dhea)
08/21/2014US20140235597 Ophthalmologic Irrigation Solutions and Method
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 2991